TERLIPRESSINE ALTAN 1 mg/8.5 ml, solution for injection 5 ampoules of 8.5 ml
Active ingredients: Terlipressin acetate, Terlipressin
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection5 ampoules of 8.5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TERLIPRESSINE ALTAN 1 mg/8,5 mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 8,5 ml
- Marketing authorisation holder
- ALTAN PHARMACEUTICALS (ESPAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Feb 2021
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68819052CIP75507581CIP133400955075813Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TERLIPRESSINEsolution | 0,85 mg · une ampoule de 8,5 mL | FT |
| ACÉTATE DE TERLIPRESSINEsolution | 1 mg · une ampoule de 8,5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.